SAN DIEGO (AP) _ Ligand Pharmaceuticals Inc. (LGND) on Thursday reported a loss of $42.5 million in its fourth quarter.
On a per-share basis, the San Diego-based company said it had a loss of $2.02. Earnings, adjusted for one-time gains and costs, came to $1.70 per share.
The drugmaker posted revenue of $59.6 million in the period.
For the year, the company reported profit of $143.3 million, or $5.96 per share. Revenue was reported as $251.5 million.
Ligand expects full-year earnings to be $6.05 per share, with revenue expected to be $224 million.
Ligand shares have declined 14 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $116.52, a fall of 24 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND